Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Aprepitant & Nausea

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Aprepitant, neurokinin-1 inhibitor, showed to increase gastric accommodation and reduce nausea and vomiting in diabetic enteropathy (DE), even if it had no effect on gastric emptying (GE)
Grover et al. 2019 Gut 68(12): 2238-2250…

References (Sources)

Can aprepitant used for nausea and vomiting be good gastrointestinal complaints?
Ugan et al. 2020
Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting
Li et al. 2019i Current Problems in Cancer 43: 100462
Gastroparesis-associated refractory nausea treated with aprepitant.
Fahler et al. 2012 Ann Pharmacother. 46: e38
Long-Term Daily Administration of Aprepitant for the Management of Intractable Nausea and Vomiting in Children With Life-Limiting Conditions: A Case Series
Patel et al. 2021c
Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021
Bonetto et al. 2021
Review
Nausea and Vomiting in 2021
Heckroth et al. 2021
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Aprepitant & Nausea

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat